Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Buy
+8,800
New +$393K 0.01% 802
2026
Q1
– Sell
-14,000
Closed -$678K – 1351
2025
Q4
$678K Buy
+14,000
New +$694K 0.02% 571

Other funds holding SNY

Winton Group's SNY Position: Q2 2026 in Review

Winton Group opened a new position in Sanofi (SNY) in Q2 2026: 8,800 shares worth $375K. The stake represents 0.01% of the portfolio and ranks #802 among its holdings. This is a return to the name: Winton Group previously reported a position in SNY as recently as Q4 2025.

Winton Group first reported a position in SNY in Q4 2025 and has held it in 2 quarters since. The position peaked at $678K in Q4 2025. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Winton Group held 8,800 shares of Sanofi worth $375K as of Q2 2026.
  • Sanofi was a new Winton Group position in Q2 2026.
  • Sanofi made up 0.01% of Winton Group's portfolio in Q2 2026, its #802 holding.
  • Winton Group first reported a position in Sanofi in Q4 2025 and has held it in 2 quarters since.
  • Winton Group's Sanofi position peaked at $678K in Q4 2025.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.